Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.

BACKGROUND & AIMS Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX; OMIM 304930) syndrome is a congenital syndrome characterized by autoimmune enteropathy, endocrinopathy, dermatitis, and other autoimmune phenomena. In the present work, we aimed to uncover the molecular basis of a distinct form of IPEX syndrome presenting at the edge of autoimmunity and severe allergy. METHODS The FOXP3 gene was sequenced, FOXP3 messenger RNA (mRNA) was quantified by real-time polymerase chain reaction (PCR), and protein expression in peripheral blood lymphocytes was analyzed by flow cytometry after intracellular staining. In coculture experiments (CD4(+)CD25(-) and CD4(+)CD25(+) cells), the functions of regulatory T cells were analyzed. Expression of interferon gamma and interleukin 2 and 4 mRNA within the inflamed intestinal mucosa was quantified by real-time PCR. RESULTS Here, we describe a distinct familial form of IPEX syndrome that combines autoimmune and allergic manifestations including severe enteropathy, food allergies, atopic dermatitis, hyper-IgE, and eosinophilia. We have identified a 1388-base pair deletion (g.del-6247_-4859) of the FOXP3 gene encompassing a portion of an upstream noncoding exon (exon -1) and the adjacent intron (intron -1). This deletion impairs mRNA splicing, resulting in accumulation of unspliced pre-mRNA and alternatively spliced mRNA. This causes low FOXP3 mRNA levels and markedly decreased protein expression in peripheral blood lymphocytes of affected patients. Numbers of CD4(+)CD25(+)FOXP3(+) regulatory T cells are extremely low, and the CD4(+)CD25(+) T cells that are present exhibit little regulatory function. CONCLUSIONS A new mutation within an upstream noncoding region of FOXP3 results in a variant of IPEX syndrome associating autoimmune and severe immunoallergic symptoms.

[1]  Nitin J. Karandikar,et al.  Transient regulatory T-cells: a state attained by all activated human T-cells. , 2007, Clinical immunology.

[2]  T. Huizinga,et al.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.

[3]  S. Ziegler,et al.  Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor1 , 2006, The Journal of Immunology.

[4]  F. Powrie,et al.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.

[5]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[6]  F. Saulsbury,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. , 2006, Journal of the American Academy of Dermatology.

[7]  S. Ziegler,et al.  Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.

[8]  F. Liew,et al.  Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Ugazio,et al.  Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  S. Riva,et al.  SERONEGATIVE AUTOIMMUNE HEPATITIS IN CHILDHOOD , 2006, Journal of Pediatric Gastroenterology and Nutrition.

[11]  A. Rudensky,et al.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Fathman,et al.  Cd4+Cd25+ regulatory T cells and their therapeutic potential. , 2006, Annual review of medicine.

[13]  S. Ziegler,et al.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. , 2005, The Journal of clinical investigation.

[14]  M. Roncarolo,et al.  CD4+ regulatory T cells: mechanisms of induction and effector function. , 2005, Autoimmunity reviews.

[15]  R. Jackson Alternative mechanisms of initiating translation of mammalian mRNAs. , 2005, Biochemical Society transactions.

[16]  H. Ochs,et al.  Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). , 2005, The Journal of pediatrics.

[17]  M. A. Curotto de Lafaille,et al.  Oral tolerance in the absence of naturally occurring Tregs. , 2005, The Journal of clinical investigation.

[18]  Fiona Powrie,et al.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level , 2005, European journal of immunology.

[19]  L. Maquat,et al.  Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. , 2005, Current opinion in cell biology.

[20]  R. Badolato,et al.  A new case of IPEX receiving bone marrow transplantation , 2005, Bone Marrow Transplantation.

[21]  S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[22]  N. Brousse,et al.  Autoimmune enteropathy: molecular concepts , 2004, Current opinion in gastroenterology.

[23]  M. Karlsson,et al.  Allergen-responsive CD4+CD25+ Regulatory T Cells in Children who Have Outgrown Cow's Milk Allergy , 2004, The Journal of experimental medicine.

[24]  J. Nicolas,et al.  Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. , 2003, Blood.

[25]  S. Ziegler,et al.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.

[26]  J. Garssen,et al.  Functional CD25– and CD25+ mucosal regulatory T cells are induced in gut‐draining lymphoid tissue within 48 h after oral antigen application , 2003, European journal of immunology.

[27]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[28]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[29]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[30]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[31]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2003 .

[32]  R. Badolato,et al.  X‐chromosome inactivation analysis in a female carrier of FOXP3 mutation , 2002, Clinical and experimental immunology.

[33]  F. Powrie,et al.  CTLA‐4 expression on antigen‐specific cells but not IL‐10 secretion is required for oral tolerance , 2002, European journal of immunology.

[34]  A. Filipovich,et al.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2002, Journal of medical genetics.

[35]  J. Wilkinson,et al.  A transgenic mouse strain with antigen-specific T cells (RAG1KO/sf/OVA) demonstrates that the scurfy (sf) mutation causes a defect in T-cell tolerization. , 2002, Comparative medicine.

[36]  A. Munnich,et al.  Trinucleotide repeat contraction: a pitfall in prenatal diagnosis of myotonic dystrophy , 2001, Journal of medical genetics.

[37]  H. Weiner,et al.  Activation of CD25+CD4+ Regulatory T Cells by Oral Antigen Administration1 , 2001, The Journal of Immunology.

[38]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[39]  Hans D. Ochs,et al.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome , 2001, Immunogenetics.

[40]  S. Antonarakis,et al.  Nomenclature for the description of human sequence variations , 2001, Human Genetics.

[41]  A. Khoruts,et al.  Generation of Anergic and Potentially Immunoregulatory CD25+CD4 T Cells In Vivo After Induction of Peripheral Tolerance with Intravenous or Oral Antigen1 , 2001, The Journal of Immunology.

[42]  A. Fischer,et al.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. , 2001, The New England journal of medicine.

[43]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[44]  A. Bowcock,et al.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. , 2000, The Journal of clinical investigation.

[45]  H. Tonoki,et al.  Identification of an autoimmune enteropathy-related 75-kilodalton antigen. , 1999, Gastroenterology.

[46]  C. Fertleman,et al.  Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: the contribution of T cells to the mucosal lesion. , 1999, Journal of pediatric gastroenterology and nutrition.

[47]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[48]  Yao-Tseng Chen,et al.  Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.

[49]  Kobayashi,et al.  A 75‐kD autoantigen recognized by sera from patients with X‐linked autoimmune enteropathy associated with nephropathy , 1998, Clinical and experimental immunology.

[50]  A. Bousvaros,et al.  Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). , 1996, Gastroenterology.

[51]  F. Deist,et al.  Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. , 1993, Gut.

[52]  M. Jonas,et al.  Congenital diabetes mellitus and fatal secretory diarrhea in two infants. , 1991, Journal of pediatric gastroenterology and nutrition.

[53]  N. Brousse,et al.  Classification of intractable diarrhea in infancy using clinical and immunohistological criteria. , 1990, Gastroenterology.

[54]  T. Halstensen,et al.  Intraepithelial T Cells of the TcRγ/δ+CD8− and Vδ1/Jδ1+ Phenotypes are Increased in Coeliac Disease , 1989 .

[55]  J. Walker-smith,et al.  Enteropathy and renal involvement in an infant with evidence of widespread autoimmune disturbance. , 1989, Journal of pediatric gastroenterology and nutrition.

[56]  B. Powell,et al.  An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. , 1982, The Journal of pediatrics.

[57]  E. Holborow,et al.  AUTOANTIBODIES AGAINST GUT EPITHELIUM IN CHILD WITH SMALL-INTESTINAL ENTEROPATHY , 1982, The Lancet.

[58]  W. Brown,et al.  Enterically induced immunologic tolerance. I. Induction of suppressor T lymphoyctes by intragastric administration of soluble proteins. , 1978, Journal of immunology.

[59]  B. Waksman,et al.  Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. , 1978, Journal of immunology.

[60]  T. Waldmann,et al.  Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity. , 1978, Annals of internal medicine.

[61]  S. Maddison,et al.  Amoebic gel-diffusion precipitin-test. Clinical evaluation in acute amoebic dysentery. , 1966, Lancet.

[62]  S. Davies,et al.  Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. , 2007, Blood.

[63]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[64]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[65]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[66]  D. Green,et al.  Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.